This company manufactures a patch insulin pump that simplifies diabetes management with continuous monitoring and personalized education. Their system uses AI to provide tailored insights and support, aiming to improve access to essential diabetes technology.
Funding
Funding not disclosed
Founders
Product
Problem
Current insulin pumps are often too complex, creating barriers to access and delaying the start of pump therapy for many individuals with diabetes, particularly those in lower socioeconomic groups. Clinician capacity is also strained by the complexity of training and support required for existing pump systems.
Solution
Tautoko Tech is developing a simplified patch insulin pump and accompanying software platform designed to be prescribed and used soon after a diabetes diagnosis. The system aims to reduce the complexity of insulin delivery, offering a user-friendly design with fewer steps for site changes compared to leading competitors. The platform incorporates a personalized care and education component, providing tailored support to both patients and clinicians. By focusing on ease of use and comprehensive support, Tautoko Tech seeks to improve access to insulin pump therapy and enhance diabetes management outcomes.
Target Audience
The primary target audience includes individuals with diabetes who could benefit from simplified insulin pump therapy, as well as clinicians seeking to improve patient access and reduce the burden of diabetes management.
Features
- Low-power patch pump design intended to last a year on a coin cell battery
- Clinically validated messaging support software, demonstrated to improve HbA1c levels
- Personalized care and education platform for both patients and clinicians
- Simplified design with fewer site change steps compared to existing pumps
- Accurate reporting and clinician support tools